Trial record 3 of 4 for:    MS and arbaclofen

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Osmotica Pharmaceutical Corp.
ClinicalTrials.gov Identifier:
NCT01743651
First received: November 28, 2012
Last updated: May 27, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)